Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
Abroad (travel likely)RecruitingPHASE2
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Multiple Sclerosis
Locations
- Johns Hopkins University, Baltimore, Maryland, United States